Clinical trial
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With…
NCT00423098 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00423098 |
|---|---|
| Title | Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare |
| Official title | A Randomized, Multicenter, Open-label, 6-month Study to Explore the Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lupus Nephritis |
| Intervention type | Drug |
| Interventions | Mycophenolate sodium, Prednisone, Methylprednisolone |
| Enrollment | 81 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 17, 2007 |
| Last update posted | Jun 28, 2011 |
| Countries | Colombia, France, Germany, Greece, Hungary, Italy, Spain, Taiwan, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: